Tetrous, Inc.

SHERMAN OAKS, CA · Founded 2019 · CIK 0002002357 · Medtech · Private

Biologic implant to promote bone-to-tendon healing at the enthesis

tetrous.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$2.2M
2 Form D · Apr 2026
6 months since last filing
Contracts
—
No federal contracts on record
Patents
18
10 granted · 8 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$444,639
Private capital raisedForm D · SEC$1,741,024
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
824PIROUETTE PHARMA INC.—$14M
825Ictero Medical, Inc.—$2.5M
826MelioLabs Inc.—$4.0M
827Tetrous, Inc.—$2.2M
828Sonex Health, Inc.—$22M
829Virtech Bio, Inc.—$500K
830149 MEDICAL INC—$450K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 10 related persons
  • Gunnar AnderssonDirector
  • Simon BerryDirector
  • John BojanowskiDirector
  • Andy CarterDirector
  • Jan IwanczykDirector
  • Matthew MuscioDirector
  • Bradley PattDirector · Executive Officer
  • Frank PhilipsDirector
  • Frank PhillipsDirector
  • Nikhil VermaDirector

Patents

USPTO · 10 granted of 18

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.